A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.
暂无分享,去创建一个
A. Hofman | A. Uitterlinden | J. Witteman | C. Newton-Cheh | B. Stricker | M. Becker | L. Visser | A. Uitterlinden | A. Hofman | C. Newton‐Cheh